PE20070206A1 - Compuestos heterociclicos como inhibidores de la catecol-o-metiltransferasa - Google Patents
Compuestos heterociclicos como inhibidores de la catecol-o-metiltransferasaInfo
- Publication number
- PE20070206A1 PE20070206A1 PE2006000859A PE2006000859A PE20070206A1 PE 20070206 A1 PE20070206 A1 PE 20070206A1 PE 2006000859 A PE2006000859 A PE 2006000859A PE 2006000859 A PE2006000859 A PE 2006000859A PE 20070206 A1 PE20070206 A1 PE 20070206A1
- Authority
- PE
- Peru
- Prior art keywords
- nitro
- dihydroxy
- alkyl
- catecol
- methyltransferase
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
- C07D209/44—Iso-indoles; Hydrogenated iso-indoles
- C07D209/46—Iso-indoles; Hydrogenated iso-indoles with an oxygen atom in position 1
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/34—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide
- A61K31/343—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide condensed with a carbocyclic ring, e.g. coumaran, bufuralol, befunolol, clobenfurol, amiodarone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
- A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
- A61K31/404—Indoles, e.g. pindolol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/425—Thiazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D275/00—Heterocyclic compounds containing 1,2-thiazole or hydrogenated 1,2-thiazole rings
- C07D275/04—Heterocyclic compounds containing 1,2-thiazole or hydrogenated 1,2-thiazole rings condensed with carbocyclic rings or ring systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
- C07D277/60—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings condensed with carbocyclic rings or ring systems
- C07D277/62—Benzothiazoles
- C07D277/64—Benzothiazoles with only hydrocarbon or substituted hydrocarbon radicals attached in position 2
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
- C07D277/60—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings condensed with carbocyclic rings or ring systems
- C07D277/62—Benzothiazoles
- C07D277/64—Benzothiazoles with only hydrocarbon or substituted hydrocarbon radicals attached in position 2
- C07D277/66—Benzothiazoles with only hydrocarbon or substituted hydrocarbon radicals attached in position 2 with aromatic rings or ring systems directly attached in position 2
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
- C07D277/60—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings condensed with carbocyclic rings or ring systems
- C07D277/84—Naphthothiazoles
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
- C07D307/77—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
- C07D307/87—Benzo [c] furans; Hydrogenated benzo [c] furans
- C07D307/88—Benzo [c] furans; Hydrogenated benzo [c] furans with one oxygen atom directly attached in position 1 or 3
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
- C07D307/77—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
- C07D307/87—Benzo [c] furans; Hydrogenated benzo [c] furans
- C07D307/89—Benzo [c] furans; Hydrogenated benzo [c] furans with two oxygen atoms directly attached in positions 1 and 3
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
- C07D333/50—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom condensed with carbocyclic rings or ring systems
- C07D333/52—Benzo[b]thiophenes; Hydrogenated benzo[b]thiophenes
- C07D333/62—Benzo[b]thiophenes; Hydrogenated benzo[b]thiophenes with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to carbon atoms of the hetero ring
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
- C07D333/50—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom condensed with carbocyclic rings or ring systems
- C07D333/52—Benzo[b]thiophenes; Hydrogenated benzo[b]thiophenes
- C07D333/62—Benzo[b]thiophenes; Hydrogenated benzo[b]thiophenes with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to carbon atoms of the hetero ring
- C07D333/68—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
- C07D333/50—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom condensed with carbocyclic rings or ring systems
- C07D333/52—Benzo[b]thiophenes; Hydrogenated benzo[b]thiophenes
- C07D333/62—Benzo[b]thiophenes; Hydrogenated benzo[b]thiophenes with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to carbon atoms of the hetero ring
- C07D333/68—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
- C07D333/70—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen attached in position 2
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
- C07D409/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Psychology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
- Thiazole And Isothizaole Compounds (AREA)
- Furan Compounds (AREA)
- Indole Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Abstract
SE REFIERE A COMPUESTOS HETEROCICLOS DE 5 ELEMENTOS BENZOFUSIONADOS DE FORMULA (I) DONDE R2 ESTA EN POSICION ORTO CON RESPECTO R3; R1 ES ORTO CON R3 Y R4 ES ORTO CON R1; R1 ES CN O NITRO; R2 ES HIDROXI; R3 ES HIDROXI; R4 ES H, ALQUILO(C1-C6), HALOALQUILO(C1-C6), CIANO, FORMILO, ENTRE OTROS; LA LINEA PUNTEADA ES UN ENLACE SIMPLE O DOBLE; DOS DE X, Y O Z SON INDEPENDIENTEMENTE CR5(R6)m, N(R7)n, O U S, Y EL TERCERO ES N(R7)n; DONDE m ES 0 O 1; n ES 0, 1 O 2; R5 ES H, ALQUILO(C1-C6), ALQUENILO(C2-C6), HALOGENO, ENTRE OTROS; R6 ES H, ALQUILO(C1-C6), ALCOXI(C1-C6), HALOGENO, ENTRE OTROS. SON PREFERIDOS: 2-(4-CLOROFENIL)-5,6-DIHIDROXI-4-NITRO-2,3-DIHIDRO-ISOINDOL-1-ONA, 5,6-DIHIDROXI-7-NITRO-3H-ISOBENZOFURAN-1-ONA, ACIDO 3-CLORO-5,6-DIHIDROXI-7-NITRO-BENZO[b]TIOFEN-2-CARBOXILICO, ENTRE OTROS. SE REFIERE TAMBIEN A UNA COMPOSICION FARMACEUTICA. DICHOS COMPUESTOS SON INHIBIDORES DE LA ENZIMA CATECOL-O-METILTRANSFERASA (COMT) SIENDO UTILES EN EL TRATAMIENTO DE LA ENFERMEDAD DE PARKINSON
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US69989805P | 2005-07-18 | 2005-07-18 |
Publications (1)
Publication Number | Publication Date |
---|---|
PE20070206A1 true PE20070206A1 (es) | 2007-05-06 |
Family
ID=37500024
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PE2006000859A PE20070206A1 (es) | 2005-07-18 | 2006-07-18 | Compuestos heterociclicos como inhibidores de la catecol-o-metiltransferasa |
Country Status (26)
Country | Link |
---|---|
US (1) | US8318785B2 (es) |
EP (1) | EP1910325B1 (es) |
JP (1) | JP5015152B2 (es) |
KR (1) | KR20080035571A (es) |
CN (1) | CN101282957B (es) |
AR (1) | AR058800A1 (es) |
AT (1) | ATE483702T1 (es) |
AU (1) | AU2006271631B2 (es) |
BR (1) | BRPI0613778A2 (es) |
CA (1) | CA2615466C (es) |
DE (1) | DE602006017378D1 (es) |
DK (1) | DK1910325T3 (es) |
EA (1) | EA017329B1 (es) |
EC (1) | ECSP088156A (es) |
ES (1) | ES2354114T3 (es) |
GE (1) | GEP20115222B (es) |
IL (1) | IL188438A (es) |
MX (1) | MX2008000875A (es) |
MY (1) | MY148644A (es) |
NO (1) | NO20080779L (es) |
NZ (1) | NZ565112A (es) |
PE (1) | PE20070206A1 (es) |
TW (1) | TW200745074A (es) |
UA (1) | UA98608C2 (es) |
WO (1) | WO2007010085A2 (es) |
ZA (1) | ZA200800368B (es) |
Families Citing this family (13)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP5369854B2 (ja) | 2008-04-21 | 2013-12-18 | 住友化学株式会社 | 有害節足動物防除組成物および縮合複素環化合物 |
JP5540640B2 (ja) | 2009-10-07 | 2014-07-02 | 住友化学株式会社 | 複素環化合物及びその有害節足動物防除用途 |
AU2011222856B2 (en) | 2010-03-04 | 2015-10-15 | Orion Corporation | Use of levodopa, carbidopa and entacapone for treating Parkinson's disease |
WO2011162364A1 (ja) | 2010-06-23 | 2011-12-29 | 住友化学株式会社 | 有害節足動物防除組成物および複素環化合物 |
WO2012013614A1 (en) * | 2010-07-27 | 2012-02-02 | F. Hoffmann-La Roche Ag | Method for the identification of catechol o-methyltransferase modulators |
WO2012087833A1 (en) | 2010-12-22 | 2012-06-28 | Abbott Laboratories | Hepatitis c inhibitors and uses thereof |
TWI638802B (zh) | 2012-05-24 | 2018-10-21 | 芬蘭商奧利安公司 | 兒茶酚o-甲基轉移酶活性抑制化合物 |
KR101551313B1 (ko) * | 2014-07-28 | 2015-09-09 | 충남대학교산학협력단 | 신규한 인덴 유도체, 이의 제조방법 및 이를 유효성분으로 함유하는 망막 질환의 예방 또는 치료용 약학적 조성물 |
JP7007292B2 (ja) * | 2015-12-18 | 2022-02-10 | ケスター、ヒューバート | 薬剤としての使用のため、特にパーキンソン病の治療のための新規二環式化合物 |
GB201617339D0 (en) | 2016-10-12 | 2016-11-23 | Lytix Biopharma As | Therapeutic compounds |
CN111253335B (zh) * | 2020-03-12 | 2023-06-06 | 浙江扬帆新材料股份有限公司 | 一种n-取代苯并异噻唑啉-3-酮衍生物的新合成方法 |
CN113121472B (zh) * | 2021-03-05 | 2022-12-16 | 上海应用技术大学 | 一种利用金配合物制备n-磺酰基四氢吡咯类化合物的方法 |
CN115286594B (zh) * | 2022-07-24 | 2023-07-25 | 浙江工业大学 | 一种以s8为原料合成醌并噻唑类化合物的方法 |
Family Cites Families (40)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3973608A (en) * | 1973-08-01 | 1976-08-10 | Zaidan Hojin Biseibutsu Kagaku Kenkyu Kai | Microbial production of certain isoflavones |
US4198415A (en) * | 1979-01-22 | 1980-04-15 | Eli Lilly And Company | Prolactin inhibiting octahydro pyrazolo[3,4-g]quinolines |
GB8406906D0 (en) * | 1984-03-16 | 1984-04-18 | Akzo Nv | Benzo-thiazole and benzothiophene derivatives |
CA1281325C (en) | 1984-06-20 | 1991-03-12 | Patrice C. Belanger | Benzofuran derivatives |
US5236952A (en) * | 1986-03-11 | 1993-08-17 | Hoffmann-La Roche Inc. | Catechol derivatives |
US5283352A (en) * | 1986-11-28 | 1994-02-01 | Orion-Yhtyma Oy | Pharmacologically active compounds, methods for the preparation thereof and compositions containing the same |
DE3832846A1 (de) | 1988-09-28 | 1990-03-29 | Bayer Ag | Verwendung von benzothiophen-2-carboxamid-s,s-dioxiden zur behandlung von krankheiten |
DE3832848A1 (de) | 1988-09-28 | 1990-03-29 | Bayer Ag | Benzothiophen-2-carboxamid-s,s-dioxide |
US5446294A (en) * | 1991-07-31 | 1995-08-29 | Texas Instruments Incorporated | Microwave heterojunction bipolar transistors suitable for low-power, low-noise and high-power applications and method for fabricating same |
JP3272819B2 (ja) | 1993-06-16 | 2002-04-08 | 協和醗酵工業株式会社 | 安息香酸およびニコチン酸誘導体の製造方法 |
US5426191A (en) * | 1993-12-03 | 1995-06-20 | Warner-Lambert Company | Process for the synthesis of 3-chlorobenzo[b]thiophene-2-carbonyl chlorides |
GB9414139D0 (en) | 1994-07-13 | 1994-08-31 | Smithkline Beecham Plc | Novel compounds |
US5863936A (en) * | 1995-04-18 | 1999-01-26 | Geron Corporation | Telomerase inhibitors |
GB9510481D0 (en) | 1995-05-24 | 1995-07-19 | Orion Yhtymae Oy | New catechol derivatives |
DE19545465A1 (de) | 1995-12-06 | 1997-06-12 | Bayer Ag | Verfahren zur Herstellung von Benzothiophen-Derivaten |
GB9626472D0 (en) * | 1996-12-20 | 1997-02-05 | Aperia Anita C | New use of comt inhibitors |
SE9701681D0 (sv) | 1997-05-05 | 1997-05-05 | Astra Ab | New compounds |
HN1999000146A (es) | 1998-09-21 | 2000-11-11 | Pfizer Prod Inc | Agentes farmaceuticos para el tratamiento de la enfermedad de parkinson, adhd y microadenomas. |
GB2344819A (en) * | 1998-12-18 | 2000-06-21 | Portela & Ca Sa | 2-Phenyl-1-(3,4-dihydroxy-5-nitrophenyl)-1-ethanones |
AU5319700A (en) | 1999-06-02 | 2000-12-18 | S. Mbua Ngale Efange | Nicotine receptor ligands |
FI109453B (fi) | 1999-06-30 | 2002-08-15 | Orion Yhtymae Oyj | Farmaseuttinen koostumus |
AU7939200A (en) | 1999-11-01 | 2001-05-14 | Clariant Finance (Bvi) Limited | Use of phthalides in stabiliser mixtures for organic materials |
FI20000635A0 (fi) * | 2000-03-17 | 2000-03-17 | Orion Yhtymae Oyj | COMT-inhibiittoreiden käyttö analgeettina |
GB0015228D0 (en) | 2000-06-21 | 2000-08-16 | Portela & Ca Sa | Substituted nitrated catechols, their use in the treatment of some central and peripheral nervous system disorders |
GB2363792A (en) | 2000-06-21 | 2002-01-09 | Portela & Ca Sa | Nitrocatechols |
FI20001593A (fi) * | 2000-07-03 | 2002-01-04 | Orion Yhtymo Oyj | Comt-entsyymiõ inhiboivaa aktiivisuutta omaavia kumariinijohdannaisia |
FI20002044A0 (fi) * | 2000-09-15 | 2000-09-15 | Orion Yhtymae Oyj | Comt-entsyymiä estäviä naftaleenijohdannaisia |
JP4623962B2 (ja) | 2001-10-22 | 2011-02-02 | ザ・リサーチ・ファウンデーション・オブ・ステイト・ユニバーシティ・オブ・ニューヨーク | タンパク質キナーゼおよびホスファターゼ阻害剤、それらを設計する方法、ならびにそれらを使用する方法 |
JP2005519915A (ja) | 2002-01-18 | 2005-07-07 | セレテック・リミテッド・ライアビリティ・カンパニー | Edg受容体に関連する症状の処置方法 |
AU2003207774A1 (en) * | 2002-01-30 | 2003-09-02 | Montana State University | Pestalotiopsis microsporia isolates and compounds derived therefrom |
DE10210779A1 (de) | 2002-03-12 | 2003-10-09 | Merck Patent Gmbh | Cyclische Amide |
CA2504344A1 (en) | 2002-11-01 | 2004-05-21 | Viropharma Incorporated | Benzofuran compounds, compositions and methods for treatment and prophylaxis of hepatitis c viral infections and associated diseases |
AU2002953533A0 (en) | 2002-12-24 | 2003-01-16 | Arthron Limited | Fc receptor modulating compounds and compositions |
GB0308025D0 (en) | 2003-04-07 | 2003-05-14 | Glaxo Group Ltd | Compounds |
BRPI0410913A (pt) | 2003-06-05 | 2006-06-27 | Warner Lambert Co | benzotiofenos substituìdos com cicloalquil e heterocicloalquil como agentes terapêuticos |
JP2007524620A (ja) | 2003-06-19 | 2007-08-30 | サイキアトリク・ゲノミクス・インコーポレーテッド | 二重機能性化合物及びその使用 |
JP2005145859A (ja) | 2003-11-13 | 2005-06-09 | Nippon Steel Chem Co Ltd | 脱水素化方法及び芳香族複素環化合物の製造方法 |
EP1697394B1 (en) | 2003-12-19 | 2007-03-21 | F.Hoffmann-La Roche Ag | Comt inhibitors |
KR20050110955A (ko) | 2004-05-20 | 2005-11-24 | 금호석유화학 주식회사 | 포토레지스트용 스트리퍼 조성물 및 이를 포토레지스트박리에 사용하는 방법 |
WO2006051154A1 (en) | 2004-11-10 | 2006-05-18 | Orion Corporation | Treatment of restless legs syndrome |
-
2006
- 2006-07-10 MY MYPI20063265A patent/MY148644A/en unknown
- 2006-07-17 CN CN2006800262421A patent/CN101282957B/zh not_active Expired - Fee Related
- 2006-07-17 MX MX2008000875A patent/MX2008000875A/es active IP Right Grant
- 2006-07-17 GE GEAP200610512A patent/GEP20115222B/en unknown
- 2006-07-17 CA CA2615466A patent/CA2615466C/en not_active Expired - Fee Related
- 2006-07-17 AT AT06764476T patent/ATE483702T1/de not_active IP Right Cessation
- 2006-07-17 JP JP2008521999A patent/JP5015152B2/ja not_active Expired - Fee Related
- 2006-07-17 UA UAA200801948A patent/UA98608C2/ru unknown
- 2006-07-17 ES ES06764476T patent/ES2354114T3/es active Active
- 2006-07-17 US US11/995,878 patent/US8318785B2/en not_active Expired - Fee Related
- 2006-07-17 BR BRPI0613778-4A patent/BRPI0613778A2/pt not_active IP Right Cessation
- 2006-07-17 WO PCT/FI2006/000257 patent/WO2007010085A2/en active Application Filing
- 2006-07-17 KR KR1020087001315A patent/KR20080035571A/ko not_active Application Discontinuation
- 2006-07-17 NZ NZ565112A patent/NZ565112A/en not_active IP Right Cessation
- 2006-07-17 DE DE602006017378T patent/DE602006017378D1/de active Active
- 2006-07-17 EP EP06764476A patent/EP1910325B1/en active Active
- 2006-07-17 AU AU2006271631A patent/AU2006271631B2/en not_active Ceased
- 2006-07-17 DK DK06764476.5T patent/DK1910325T3/da active
- 2006-07-17 EA EA200800357A patent/EA017329B1/ru not_active IP Right Cessation
- 2006-07-18 PE PE2006000859A patent/PE20070206A1/es not_active Application Discontinuation
- 2006-07-18 TW TW095126141A patent/TW200745074A/zh unknown
- 2006-07-18 AR ARP060103074A patent/AR058800A1/es not_active Application Discontinuation
-
2007
- 2007-12-26 IL IL188438A patent/IL188438A/en not_active IP Right Cessation
-
2008
- 2008-01-11 ZA ZA200800368A patent/ZA200800368B/xx unknown
- 2008-01-31 EC EC2008008156A patent/ECSP088156A/es unknown
- 2008-02-13 NO NO20080779A patent/NO20080779L/no not_active Application Discontinuation
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
PE20070206A1 (es) | Compuestos heterociclicos como inhibidores de la catecol-o-metiltransferasa | |
PE20091175A1 (es) | Derivados bis-(sulfonilamino) en terapia 205 | |
PE20090601A1 (es) | Derivados de piridin-il-oxi-piridinas como inhibidores de alk5 | |
PE20061439A1 (es) | DERIVADOS DE 2-AMIDO-6-AMINO-8-OXO-PURINA COMO MODULADORES DEL RECEPTOR Toll (TLR) | |
PE20090074A1 (es) | DERIVADOS DE BENCIMIDAZOL COMO MODULADORES DE LOS RECEPTORES DE GLUTAMATO METABOTROPICOS (mGluR) | |
PE20021005A1 (es) | Quinazolinas como inhibidores de mmp-13 | |
PE20091008A1 (es) | Derivados heterociclicos como moduladores de fosfoinositida 3-cinasa | |
PT1204650E (pt) | Compostos de 2-arilbenzazole substituido e sua utilizacao como agentes antitumorais. | |
PA8632701A1 (es) | Compuestos terapeuticos | |
PE20070181A1 (es) | DERIVADOS DE CICLOHEXILAMINISOQUINOLONA COMO INHIBIDORES DE Rho-QUINASA | |
PE20080527A1 (es) | Derivado de pirimidina como inhibidor de la fosfatidilinositol 3-quinasa (pi3k) | |
PE20090960A1 (es) | Derivados de quinazolinadiona, su preparacion y sus aplicaciones terapeuticas | |
CR10381A (es) | Uso de bifenilamidas de acido arilcarboxilico para el tratamiento de semillas | |
GB0510584D0 (en) | Organic compounds | |
PE20081316A1 (es) | COMPUESTOS HETEROCICLICOS QUE MODULAN LA ACTIVIDAD DE LA ESTEROIL-CoA-DESATURASA | |
PE20071322A1 (es) | Derivados de 2-morfolinopirimidina como inhibidores de fosfatidinoinositol(pi) 3-quinasa | |
PE20080948A1 (es) | Derivados de imidazol como moduladores de la senda de hedgehog | |
TW200720250A (en) | Benzene, pyridine, and pyridazine derivatives | |
BRPI0608732A2 (pt) | composto ou um sal, hidrato, solvato, complexo ou pró-droga farmaceuticamente aceitável do mesmo, sal de um composto, processo para a preparação de um composto, uso de um composto, composição farmacêutica, e, produto | |
PE20061303A1 (es) | Composicion farmaceutica que comprende oxaprozina | |
PE20061297A1 (es) | Compuestos derivados de cromano y cromeno moduladores del receptor de serotonina 5-ht2c | |
PE20090546A1 (es) | Derivados de imidazol como antagonistas de los receptores de quimioquina ccr-2, ccr-3 y ccr-5 | |
PE20081596A1 (es) | Derivados fluorinados de deferiprona | |
ATE537830T1 (de) | Nicotinamid derivate und ihre verwendung als therapeutika | |
AR074608A1 (es) | Derivados de 2-(piperidin-1-il)-4-heterociclil-tiazol-5-carboxilico para infecciones bacterianas |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FG | Grant, registration | ||
FD | Application declared void or lapsed |